Nabilone

DB00486ApprovedInvestigationalSmall moleculeCannabinoids and similars

Nabilone is a synthetic delta-9-THC used in the treatment of anorexia and weight loss in HIV patients as well as nausea and vomiting in cancer chemotherapy. Nabilone (marketed as Cesamet) is a synthetic form of delta-9-tetrahydrocannabinol (Δ⁹-THC), the primary psychoactive component of cannabis (marijuana).

Chemical structure of Nabilone
Mechanism
Curator reviewed · 2 references
Primary indication
Nabilone is indicated for the treatment of the nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.Curator reviewed · 1 structured indication
Formula / weight
C24H36O3 · 372.5408 g/mol (avg)
First approval
Canada, 2010 · United States, 2009
Code names
Cpd 109514 · LY 109 514
Brand names
  • Cesamet

Resolves to

Structure
InChIKeyGECBBEABIDMGGL-RTBURBONSA-NSMILES[H][C@@]12CC(=O)CC[C@@]1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC

What you can answer from here — as of August 31, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,343Drug interactionsStructured to mechanism, not free text
Sign in
33Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
22Marketed productsAcross 3 countries and 8 labellers
Sign in
1ATC codeIncluding every combination product, plus 33 drug categories
Sign in
31+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Nabilone, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account